Clinical Trial Update: Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating antiviral prophylaxis for HBsAg-positive or HBcAb-positive/HBsAb-negative patients starting anti-TNF therapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Hepatitis B
• Juvenile Idiopathic Arthritis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Snippet

Sponsor: Seoul National University Hospital | Conditions: Chronic Hepatitis B, Rheumatoid Arthritis | Phase 3 | Status: TERMINATED